Gordon E. Catton

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy

Prognostic factors after surgery for locally recurrent rectal cancer: An overview

Pancreatic cancer

Hyperthermia in combined treatment of cancer

The role of palliative radiation therapy in symptomatic locally advanced gastric cancer

Management of borderline and locally advanced pancreatic cancer: Where do we stand?

Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group.

Pancreatic cancer

Heating the patient: a promising approach?

Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators

A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer

Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy

Advanced pancreatic carcinoma: current treatment and future challenges

The Glasgow Prognostic Score Is a Good Predictor of Treatment Outcome in Patients with Unresectable Pancreatic Cancer

Neoadjuvant chemotherapy in locally advanced gastric carcinoma—a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

The cellular and molecular basis of hyperthermia

Pancreatic cancer

Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases

Colorectal cancer

Preoperative Hyperthermia Combined with Radiochemotherapy in Locally Advanced Rectal Cancer

Pancreatic Adenocarcinoma

Six Hundred Fifty Consecutive Pancreaticoduodenectomies in the 1990s

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

Macrophages as regulators of tumour immunity and immunotherapy

Adjuvant therapy in pancreatic cancer: historical and current perspectives

Pancreatic Cancer

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice

Pre- or Postoperative Radiotherapy in Rectal and Rectosigmoid Carcinoma Report from a Randomized Multicenter Trial

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study

The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer

Pancreatic cancer

Randomized Phase III Multi-Institutional Study of TNFerade Biologic With Fluorouracil and Radiotherapy for Locally Advanced Pancreatic Cancer: Final Results

Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles

Chemoradiotherapy in the Management of Locally Advanced Pancreatic Carcinoma: A Qualitative Systematic Review

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib

Chemotherapy prolongs survival in inoperable pancreatic carcinoma

Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer

The role of radiation therapy in the control of pain from pancreatic carcinoma

Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies

International experiences with the Hospital Anxiety and Depression Scale-A review of validation data and clinical results

Chronic Inflammation and Cytokines in the Tumor Microenvironment

Pancreatic Adenocarcinoma Clinical Practice Guidelines in Oncology

Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.

Combination chemo-radiotherapy for residual, recurrent or inoperable carcinoma of the rectum: E.C.O.G. study (EST 3276)